The Bristol Myers Squibb Bounce: A Patented Solution? Bristol Myers Squibb's recent stock performance has investors perplexed.
Despite a patent cliff looming on the horizon, the company's shares have remained stable – even showing modest gains in the past year.
This stability is not necessarily a given, however; instead, it may be an indication of the company's ability to adapt and innovate.